drugset / Trial / NCT04191434

Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma

NCT04191434 ↗

Phase 3 Unknown 134 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Flamboyant 125/12 association in adults with asthma.

Timeline

Start
2022-07-22
Primary completion
2023-05
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide/formoterol Unknown 6 unknown Inhaled
Comparator Budesonide/formoterol Unknown 200 unknown Inhaled
Subject Flamboyant 125/12 Unknown 12 unknown Inhaled
Subject Flamboyant 125/12 Unknown 125 unknown Inhaled

Indications